Evidence map›Paper›PMID 22153502›Full record

ArticleStructure (London, England : 1993)2011

Galline Ex-FABP is an antibacterial siderocalin and a lysophosphatidic acid sensor functioning through dual ligand specificities.

Colin Correnti, Matthew C Clifton, Rebecca J Abergel, Ben Allred, Trisha M Hoette, Mario Ruiz, Ranieri Cancedda, Kenneth N Raymond, Fiorella Descalzi, Roland K Strong

Open access · bronzeAbstract read
In one paragraph

Article in Structure (London, England : 1993), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. The anti-bacterial iron-restriction defence mechanisms of egg white; the potential role of three lipocalin-like proteins in resistance against Salmonella.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2019
    Article
  10. Article
  11. Article
  12. Coordination Chemistry of Microbial Iron Transport.Accounts of chemical research · 2015
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Colin CorrentiDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Matthew C Clifton
Rebecca J Abergel
Ben Allred
Trisha M Hoette
Mario Ruiz
Ranieri Cancedda
Kenneth N Raymond
Fiorella Descalzi
Roland K Strong
University of California, Berkeley · USUniversity of Genoa · ITFred Hutch Cancer Center · USInstituto de Biomedicina y Genética Molecular de Valladolid · ES

Funding

Research Education About Cancer and Health (REACH) CoreU54CA132381 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KAREN R PETERSON · 2007 to 2026
$25.3M
Undergraduate Student Training in Cancer ResearchU54CA132383 · NCI · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI MICHELE Irene SHUSTER · 2007 to 2026
$21.4M
Coordination Chemistry of Microbial Iron Transport CompoundsR01AI011744 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI RAYMOND, KENNETH N · 1986 to 2013
$4.1M
Structure/function studies of CTLD NK immunoreceptorsR01AI048675 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STRONG, ROLAND K · 2001 to 2010
$3.1M
Microbial siderophore-specific innate immune responsesR01AI059432 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STRONG, ROLAND K · 2005 to 2008
$1.1M
RIGAKU/MSC HIGH-THROUGHPUT HOMELAB X-RAY CRYSTALLOGRAPHY SYSTEM: IMMUNOLOGYS10RR022380 · NCRR · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STRONG, ROLAND K · 2005 to 2005
$459k
NCI NIH HHS U54 CA132381NCI NIH HHS U54 CA132383NCRR NIH HHS S10 RR022380NIAID NIH HHS AI011744NIAID NIH HHS AI48675NIAID NIH HHS R01 AI011744NIAID NIH HHS R01 AI048675NIAID NIH HHS R01 AI059432
6 · The paper itself

Abstract

Galline Ex-FABP was identified as another candidate antibacterial, catecholate siderophore binding lipocalin (siderocalin) based on structural parallels with the family archetype, mammalian Siderocalin. Binding assays show that Ex-FABP retains iron in a siderophore-dependent manner in both hypertrophic and dedifferentiated chondrocytes, where Ex-FABP expression is induced after treatment with proinflammatory agents, and specifically binds ferric complexes of enterobactin, parabactin, bacillibactin and, unexpectedly, monoglucosylated enterobactin, which does not bind to Siderocalin. Growth arrest assays functionally confirm the bacteriostatic effect of Ex-FABP in vitro under iron-limiting conditions. The 1.8 Å crystal structure of Ex-FABP explains the expanded specificity, but also surprisingly reveals an extended, multi-chambered cavity extending through the protein and encompassing two separate ligand specificities, one for bacterial siderophores (as in Siderocalin) at one end and one specifically binding copurified lysophosphatidic acid, a potent cell signaling molecule, at the other end, suggesting Ex-FABP employs dual functionalities to explain its diverse endogenous activities.

Indexed as

AnimalsAnti-Bacterial AgentsChick EmbryoCrystallography, X-RayLigandsLysophospholipidsProtaminesSiderophoresAnti-Bacterial AgentsgallineLigandslysophosphatidic acidLysophospholipidsProtaminesSiderophores

Identifiers

PMID22153502
PMCPMC3240821
OpenAlexW2000167480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.